Bayer Retained Earnings (Accumulated Deficit) 2012-2025 | BAYRY

Bayer retained earnings (accumulated deficit) for the quarter ending December 31, 2025 were $0M, a 0% increase year-over-year.

  • Bayer retained earnings (accumulated deficit) for 2025 were $0B, a 0% decline from 2024.
  • Bayer retained earnings (accumulated deficit) for 2024 were $0B, a 0% decline from 2023.
  • Bayer retained earnings (accumulated deficit) for 2023 were $0B, a 0% decline from 2022.

Bayer Retained Earnings (Accumulated Deficit) 2012-2025 | BAYRY

  • Bayer retained earnings (accumulated deficit) for 2025 were $0B, a 0% decline from 2024.
  • Bayer retained earnings (accumulated deficit) for 2024 were $0B, a 0% decline from 2023.
  • Bayer retained earnings (accumulated deficit) for 2023 were $0B, a 0% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Innoviva (INVA)$1.8B